Benefit from adjuvant cyclophosphamide. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Spleen Lymph Nodes Bone Marrow T-Lymphocytes Antilymphocyte Serum

Organisms4

Mice, Inbred BALB C Mice, Inbred C57BL Mice, Inbred Strains Mice, Inbred C3H

Diseases36

Breast Neoplasms Leukopenia Lymphoma, Non-Hodgkin Cystitis Neoplasm Recurrence, Local Recurrence Lymphatic Metastasis Wegener Granulomatosis Neutropenia Lupus Nephritis Hypersensitivity, Delayed Neoplasm Metastasis Anemia, Aplastic Lung Neoplasms Lymphoma, Large B-Cell, Diffuse Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Neoplasms Vomiting Leukemia, Lymphocytic, Chronic, B-Cell Graft vs Host Disease Amenorrhea Thrombocytopenia Multiple Myeloma Microscopic Polyangiitis Carcinoma, Small Cell Lymphoma Disease Progression Adenocarcinoma Lymphoma, Follicular Nausea Hematologic Diseases Disease Models, Animal Hodgkin Disease Nephrotic Syndrome Neoplasms, Experimental Vasculitis

Chemicals and Drugs60

Cyclophosphamide Methotrexate Fluorouracil Adjuvants, Immunologic Doxorubicin Vincristine Freund's Adjuvant Phosphoramide Mustards Antineoplastic Agents, Alkylating Prednisone Immunosuppressive Agents Epirubicin Etoposide Adjuvants, Pharmaceutic Thiotepa Busulfan Prednisolone Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents Granulocyte Colony-Stimulating Factor Vidarabine Methylprednisolone Cisplatin Tamoxifen Carmustine Melphalan Ifosfamide Azathioprine Mesna Paclitaxel Antineoplastic Agents, Hormonal Aluminum Hydroxide Chlorambucil Mitoxantrone Bleomycin Antibodies, Monoclonal Carboplatin Acrolein Procarbazine Taxoids Alkylating Agents Anthracyclines Dexamethasone Cytarabine Vaccines Levamisole Immunoglobulin G Receptor, erbB-2 Vinblastine Lomustine Receptors, Estrogen Antibiotics, Antineoplastic Semustine Cancer Vaccines Antilymphocyte Serum Myeloablative Agonists Antibodies, Monoclonal, Humanized Recombinant Proteins Amifostine Mechlorethamine

Analytical, Diagnostic and Therapeutic Techniques and Equipment53

Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Treatment Outcome Radiotherapy, Adjuvant Drug Administration Schedule Disease-Free Survival Pulse Therapy, Drug Survival Analysis Survival Rate Remission Induction Follow-Up Studies Neoplasm Staging Bone Marrow Transplantation Drug Therapy, Combination Prognosis Transplantation, Autologous Hematopoietic Stem Cell Transplantation Whole-Body Irradiation Administration, Metronomic Immunosuppression Retrospective Studies Transplantation Conditioning Clinical Trials as Topic Prospective Studies Neoadjuvant Therapy Immunization Administration, Oral Transplantation, Homologous Leukocyte Count Randomized Controlled Trials as Topic Infusions, Intravenous Hematopoietic Stem Cell Mobilization Actuarial Analysis Immunotherapy Kaplan-Meier Estimate Injections, Intravenous Random Allocation Mastectomy, Radical Pilot Projects Mastectomy Neoplasm Transplantation Immunization, Passive Salvage Therapy Drug Evaluation Administration, Intranasal Feasibility Studies Risk Factors Leukapheresis Disease Models, Animal Multivariate Analysis Neoplasms, Experimental Proportional Hazards Models

Phenomena and Processes7

Time Factors Dose-Response Relationship, Drug Antibody Formation Leukocyte Count Premenopause Immunity, Cellular Biotransformation

Information Science1

Health Care19

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Retrospective Studies Clinical Trials as Topic Prospective Studies Immunization Randomized Controlled Trials as Topic Insurance Benefits Actuarial Analysis Kaplan-Meier Estimate Random Allocation Pilot Projects Feasibility Studies Risk Factors Multivariate Analysis Proportional Hazards Models

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Cyclophosphamide Chemotherapy, Adjuvant Methotrexate Fluorouracil Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Adjuvants, Immunologic Doxorubicin Vincristine Freund's Adjuvant Phosphoramide Mustards Antineoplastic Agents, Alkylating Prednisone Combined Modality Therapy Treatment Outcome Radiotherapy, Adjuvant Drug Administration Schedule Immunosuppressive Agents Epirubicin Disease-Free Survival Pulse Therapy, Drug Etoposide Adjuvants, Pharmaceutic Survival Analysis Thiotepa Busulfan Survival Rate Prednisolone Remission Induction Time Factors Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents Follow-Up Studies Neoplasm Staging Granulocyte Colony-Stimulating Factor Leukopenia Bone Marrow Transplantation Dose-Response Relationship, Drug Lymphoma, Non-Hodgkin Vidarabine Drug Therapy, Combination Prognosis Transplantation, Autologous Methylprednisolone Cisplatin Hematopoietic Stem Cell Transplantation Cystitis Neoplasm Recurrence, Local Whole-Body Irradiation Administration, Metronomic Tamoxifen Recurrence Carmustine Melphalan Immunosuppression Mice, Inbred BALB C Retrospective Studies Transplantation Conditioning Clinical Trials as Topic Ifosfamide Azathioprine Lymphatic Metastasis Prospective Studies Wegener Granulomatosis Mesna Neoadjuvant Therapy Neutropenia Antibody Formation Lupus Nephritis Immunization Paclitaxel Antineoplastic Agents, Hormonal Aluminum Hydroxide Administration, Oral Chlorambucil Mitoxantrone Spleen Bleomycin Hypersensitivity, Delayed Antibodies, Monoclonal Carboplatin Acrolein Transplantation, Homologous Procarbazine Leukocyte Count Randomized Controlled Trials as Topic Infusions, Intravenous Insurance Benefits Taxoids Hematopoietic Stem Cell Mobilization Mice, Inbred C57BL Alkylating Agents Anthracyclines Neoplasm Metastasis Dexamethasone Cytarabine Anemia, Aplastic Actuarial Analysis Lung Neoplasms Lymphoma, Large B-Cell, Diffuse

No FAQ available that match "benefit from adjuvant cyclophosphamide"